NCT07675902

Brief Summary

The aim of this research was to examine the accuracy of transcerebellar diameter to abdominal circumference ratio (TCD/AC) and mid-thigh circumference and femur length (MTC/FL) in estimating the gestational age of healthy and abnormally growing fetuses.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Oct 2023

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2023

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2024

Completed
1.7 years until next milestone

First Submitted

Initial submission to the registry

June 23, 2026

Completed
7 days until next milestone

First Posted

Study publicly available on registry

June 30, 2026

Completed
Last Updated

June 30, 2026

Status Verified

June 1, 2026

Enrollment Period

1 year

First QC Date

June 23, 2026

Last Update Submit

June 23, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Diagnostic accuracy of transcerebellar diameter to abdominal circumference ratio (TCD/AC) ratio

    Assessment of the diagnostic performance of the transcerebellar diameter to abdominal circumference ratio (TCD/AC) in predicting intrauterine growth restriction (IUGR)

    At the time of ultrasound examination (24-28 weeks of gestation)

Study Arms (2)

Group A

Pregnant women with normal fetal growth.

Device: Fetal Ultrasound Assessment

Group B

Pregnant women suffering from intrauterine growth restriction (IUGR).

Device: Fetal Ultrasound Assessment

Interventions

All enrolled pregnant women underwent a standardized obstetric ultrasound examination between 24 and 28 weeks of gestation.

Group AGroup B

Eligibility Criteria

Age18 Years - 35 Years
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsPregnant women
Healthy VolunteersNo
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

This prospective study was conducted on 100 pregnant cases at the department of Obstetrics of Tanta University Hospital.

You may qualify if:

  • Pregnant women aged 18 to 35 years old.
  • weeks of gestation
  • Primigravida
  • Single viable fetus
  • Reliable Last Menstrual Period (LMP) or first trimester ultrasonography to confirm gestational age.

You may not qualify if:

  • Chromosomal abnormalities.
  • Any medical disease that affect fetal growth.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Tanta University

Tanta, El-Gharbia, 31527, Egypt

Location

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Resident at Obstetrics and Gynecology Department, Faculty of Medicine, Tanta University, Tanta, Egypt.

Study Record Dates

First Submitted

June 23, 2026

First Posted

June 30, 2026

Study Start

October 1, 2023

Primary Completion

October 1, 2024

Study Completion

October 1, 2024

Last Updated

June 30, 2026

Record last verified: 2026-06

Data Sharing

IPD Sharing
Will share

The data will be available upon a reasonable request from the corresponding author after the end of study for one year.

Shared Documents
STUDY PROTOCOL
Time Frame
After the end of study for one year.
Access Criteria
The data will be available upon a reasonable request from the corresponding author.

Locations